Risk factors for HIV-1 seroconversion among injection drug users
A case-control study
Bibliographic Data
| ID | 11028692 |
|---|---|
| Authors | Dale D Chitwood (Sylvester Comprehensive Cancer Center), David Griffin (0000-0001-8077-8610, University of Miami), D K Griffin, Mary Comerford (University of Miami), J Bryan Page (University of Miami), Edward Trapido (0000-0002-9612-4555, University of Miami), E J Trapido, Shenghan Lai (0000-0003-1340-9609, University of Miami), Clyde B Mccoy (Faculty of Public Health) |
| Year | 1995 |
| Volume | 85 |
| Issue | 11 |
| Pages | 1538-1542 |
| Publication date | 1995-11-01 |
| Peer Reviewed | Yes |
| Open Access | No |
| Type | ARTICLE |
| Venue | American Journal of Public Health (JOURNAL) |
| Journal identifiers | ISSN: 0090-0036 • E-ISSN: 1541-0048 |
| Publisher | American Public Health Association (PUBLISHER • US) |
| DOI | 10.2105/ajph.85.11.1538 |
| PMID | 7485667 |
| OpenAlex | W2089914402 |
| Language | EN |
| Citations received | 15 |
| References cited | 28 |
OBJECTIVES. A nested case-control study was conducted in Miami, Fla, to determine risk factors associated with human immunodeficiency virus type 1 (HIV-1) seroconversion among injection drug users. METHODS. The study identified 21 incident cases of HIV-1 infection and 76 unmatched controls from two longitudinal cohorts of injection drug users. One cohort consisted of individuals who originally had been recruited from treatment centers; a second cohort was recruited from the "street." Logistic regression analyses that adjusted for age, gender, and race were performed. RESULTS. The final model determined that the primary independent risk factor that best explained the risk for seroconversion was sharing injection equipment in the year prior to conversion; a marginal risk factor was presence of sexually transmitted disease during this same period. CONCLUSIONS. Both an injection component and a sexual component play a role in seroconversion among injection drug users, although the injection component is much stronger
Cohort · Cohort study · Drug injection · Human immunodeficiency virus (HIV) · Logistic regression · Risk factor · Seroconversion · Demography · HIV, Drug Use, Sexual Risk · HIV/AIDS Research and Interventions · Immunology · Internal Medicine · Medicine · Sex work and related issues
Adolescent substance use and sexual risk-taking behavior
Do Needle Syringe Programs Reduce HIV Infection Among Injecting Drug Users
Cross sectional study of factors associated to self-reported blood-borne infections among drug users
“Here’s What I’d Do …”
Seroconversion Issues Among Out-of-Treatment Injection Drug Users
Barriers to practicing risk reduction strategies among people who inject drugs
Risky behaviors for HIV infection among male incarcerated injection drug users in Taiwan
The public health and social impacts of drug market enforcement
Seroprevalence of HCV and HIV infection among clients of the nation’s longest-standing statewide syringe exchange program
A review of network simulation models of hepatitis C virus and HIV among people who inject drugs
Effectiveness of sterile needle and syringe programmes
Disparities of Covid-19 and HIV Occurrence Based on Neighborhood Infection Incidence in Philadelphia, Pennsylvania
The impact of a police drug crackdown on drug injectors' ability to practice harm reduction
Use of Needles and Syringes in Miami and Valencia
Injection drug users' practices and attitudes toward intervention and potential for reducing the transmission of HIV
Risk Factors for Human Immunodeficiency Virus Infection in Intravenous Drug Users
Human immunodeficiency virus infection in heterosexual intravenous drug users in San Francisco
HIV infection, genital ulcer disease, and crack cocaine use among patients attending a clinic for sexually transmitted diseases
HIV prevalence and risk behavior among injecting drug users who participate in "low-threshold" methadone programs in Amsterdam
Shooting Scenarios and Risk of HIV-1 Infection
Intravenous Drug Use and HIV Infection in Miami
| Unique citing works | 15 |
|---|---|
| Citations per year | 0,52 |
| Citation span | 1997 - 2022 (26) |
| Citation velocity | historical |
| Highly cited | No |
| Citation types | Neutral: 15 |